Production of fermentescible sugar from paper-pulp: looking for a dynamic and multiscale integrated models based on physical parameters

In order to achieve economic viability, the biorefining of lignocellulosic resources must be operated at very high feedstock dry matter content. The paper pulp product is rather appropriate for modern biorefining, because it displays low lignin content, is free of inhibitory compounds that can perturb fermentations and is devoid of microbial contaminants. Nevertheless the enzyme liquefaction and saccharification of paper-like pulps are subject to the same constraints as other pulps obtained via alternative methods such as steam explosion or dilute acid hydrolysis. Therefore, the better scientific understanding and ultimately the technical mastering of these critical biocatalytic reactions, which involve complex matrices at high solids content, is currently a major challenge that must be met in order to facilitate the intensification of biorefining operations. Our aim is to investigate dynamic of transfer phenomena and limitation of biocatalytic reactions with lignocelluloses resources under high concentration conditions. Our action focuses on the identification of rate limiting steps of the liquefactions mechanisms by physical and biochemical characterization of pre-treated lignocellulosic resources at a macroscopic scale (power consumption, rheology), microscopic scale (particle size, morphology) and molecular scale (chemical analysis). Firstly, based on real and model matrices and using Metzner & Reed concept, non-Newtonian rheological behaviour of fiber suspensions are described by a structured rheological model including parameters such as concentration, size and shape. Secondly, the complex relationships between fibre structure, degradation, chemical composition and rheological behaviour is investigated. To this end, physical and biochemical on line and off-line analyses will be conducted during bioreaction with a specific and fully instrumented bioprocess. Relation between apparent viscosity change and biocatalytic degradation of fiber may then be discussed

In-situ physical analysis of cellulose fibre suspensions during enzymatic hydrolysis

In-situ physical analysis of cellulose fibre suspensions during enzymatic hydrolysi

Neuron-Derived Semaphorin 3A Is an Early Inducer of Vascular Permeability in Diabetic Retinopathy via Neuropilin-1

SummaryThe deterioration of the inner blood-retinal barrier and consequent macular edema is a cardinal manifestation of diabetic retinopathy (DR) and the clinical feature most closely associated with loss of sight. We provide evidence from both human and animal studies for the critical role of the classical neuronal guidance cue, semaphorin 3A, in instigating pathological vascular permeability in diabetic retinas via its cognate receptor neuropilin-1. We reveal that semaphorin 3A is induced in early hyperglycemic phases of diabetes within the neuronal retina and precipitates initial breakdown of endothelial barrier function. We demonstrate, by a series of orthogonal approaches, that neutralization of semaphorin 3A efficiently prevents diabetes-induced retinal vascular leakage in a stage of the disease when vascular endothelial growth factor neutralization is inefficient. These observations were corroborated in TgCre-Esr1/Nrp1flox/flox conditional knockout mice. Our findings identify a therapeutic target for macular edema and provide further evidence for neurovascular crosstalk in the pathogenesis of DR

Functioning of the dimeric GABA(B) receptor extracellular domain revealed by glycan wedge scanning

The G-protein-coupled receptor (GPCR) activated by the neurotransmitter GABA is made up of two subunits, GABA(B1) and GABA(B2). GABA(B1) binds agonists, whereas GABA(B2) is required for trafficking GABA(B1) to the cell surface, increasing agonist affinity to GABA(B1), and activating associated G proteins. These subunits each comprise two domains, a Venus flytrap domain (VFT) and a heptahelical transmembrane domain (7TM). How agonist binding to the GABA(B1) VFT leads to GABA(B2) 7TM activation remains unknown. Here, we used a glycan wedge scanning approach to investigate how the GABA(B) VFT dimer controls receptor activity. We first identified the dimerization interface using a bioinformatics approach and then showed that introducing an N-glycan at this interface prevents the association of the two subunits and abolishes all activities of GABA(B2), including agonist activation of the G protein. We also identified a second region in the VFT where insertion of an N-glycan does not prevent dimerization, but blocks agonist activation of the receptor. These data provide new insight into the function of this prototypical GPCR and demonstrate that a change in the dimerization interface is required for receptor activation

Évaluation du risque simplifiée du tomato brown rugose fruit virus pour la France métropolitaine: Avis de l'Anses. Rapport d'expertise collective

Évaluation du risque simplifiée du tomato brown rugose fruit virus pour la France métropolitaine. Avis de l'Anses. Rapport d'expertise collectiv

Prenatal Arsenic Exposure Alters Gene Expression in the Adult Liver to a Proinflammatory State Contributing to Accelerated Atherosclerosis

The mechanisms by which environmental toxicants alter developmental processes predisposing individuals to adult onset chronic disease are not well-understood. Transplacental arsenic exposure promotes atherogenesis in apolipoprotein E-knockout (ApoE−/−) mice. Because the liver plays a central role in atherosclerosis, diabetes and metabolic syndrome, we hypothesized that accelerated atherosclerosis may be linked to altered hepatic development. This hypothesis was tested in ApoE−/− mice exposed to 49 ppm arsenic in utero from gestational day (GD) 8 to term. GD18 hepatic arsenic was 1.2 µg/g in dams and 350 ng/g in fetuses. The hepatic transcriptome was evaluated by microarray analysis to assess mRNA and microRNA abundance in control and exposed pups at postnatal day (PND) 1 and PND70. Arsenic exposure altered postnatal developmental trajectory of mRNA and microRNA profiles. We identified an arsenic exposure related 51-gene signature at PND1 and PND70 with several hubs of interaction (Hspa8, IgM and Hnf4a). Gene ontology (GO) annotation analyses indicated that pathways for gluconeogenesis and glycolysis were suppressed in exposed pups at PND1, and pathways for protein export, ribosome, antigen processing and presentation, and complement and coagulation cascades were induced by PND70. Promoter analysis of differentially-expressed transcripts identified enriched transcription factor binding sites and clustering to common regulatory sites. SREBP1 binding sites were identified in about 16% of PND70 differentially-expressed genes. Western blot analysis confirmed changes in the liver at PND70 that included increases of heat shock protein 70 (Hspa8) and active SREBP1. Plasma AST and ALT levels were increased at PND70. These results suggest that transplacental arsenic exposure alters developmental programming in fetal liver, leading to an enduring stress and proinflammatory response postnatally that may contribute to early onset of atherosclerosis. Genes containing SREBP1 binding sites also suggest pathways for diabetes mellitus and rheumatoid arthritis, both diseases that contribute to increased cardiovascular disease in humans